Top In Vivo CAR-T Therapy companies

The 5 key players our In Vivo CAR-T Therapy report profiles, and other companies free public records show in this market.

Key players in In Vivo CAR-T Therapy

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the In Vivo CAR-T Therapy market
#CompanyWebsiteOur reports
1 Capstan Therapeutics (AbbVie) — 33 reports
2 Umoja Biopharma — 33 reports
3 Interius BioTherapeutics — 33 reports
4 Kelonia Therapeutics — 33 reports
5 EsoBiotec (AstraZeneca) — 33 reports

Also active in In Vivo CAR-T Therapy

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in In Vivo CAR-T Therapy, from free public records
CompanyWhere public records show them
Chongqing Precision Biotech Co., Ltd

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in In Vivo CAR-T Therapy

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Chongqing Precision Biotech Co., Ltd 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

In Vivo CAR-T Therapy reports by place

One report for each place. Each tile opens that place's report.

Regions 7

Countries 26

Compare all 33 places for In Vivo CAR-T Therapy, with active trials

Get the full In Vivo CAR-T Therapy report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.